


Healthcare News Roundup: Neuro
HSMN NewsFeed - 4 Jan 2008
ImaRx Provides Update on TUCSON Phase I/II Clinical Trial in Acute Ischemic Stroke
ImaRx Provides Update on TUCSON Phase I/II Clinical Trial in Acute Ischemic Stroke
HSMN NewsFeed - 21 Dec 2007
Dennis L. Smith Appointed President and Chief Executive Officer of Solstice Neurosciences, Inc.
Dennis L. Smith Appointed President and Chief Executive Officer of Solstice Neurosciences, Inc.
HSMN NewsFeed - 20 Dec 2007
Alphatec Holdings, Inc. Acquires an Exclusive Worldwide License for Innovative Pedicle Screw Technology
Alphatec Holdings, Inc. Acquires an Exclusive Worldwide License for Innovative Pedicle Screw Technology
HSMN NewsFeed - 18 Dec 2007
IST Study Demonstrates Benefits of Minimally Invasive Lumbar Fusion Surgery
IST Study Demonstrates Benefits of Minimally Invasive Lumbar Fusion Surgery
HSMN NewsFeed - 17 Dec 2007
Lilly and BioMS Medical Announce Global Licensing and Development Agreement
Lilly and BioMS Medical Announce Global Licensing and Development Agreement
HSMN NewsFeed - 14 Dec 2007
Neurochem announces European opinion for Eprodisate (KIACTA(TM)) for the treatment of AA amyloidosis
Neurochem announces European opinion for Eprodisate (KIACTA(TM)) for the treatment of AA amyloidosis
HSMN NewsFeed - 13 Dec 2007
Neurologix Gene Therapy Approach to Parkinson's Disease Granted Fast Track Designation From FDA
Neurologix Gene Therapy Approach to Parkinson's Disease Granted Fast Track Designation From FDA
HSMN NewsFeed - 13 Dec 2007
Neupro(R) Filed with the FDA for the Treatment of Advanced-Stage Parkinson's Disease
Neupro(R) Filed with the FDA for the Treatment of Advanced-Stage Parkinson's Disease
HSMN NewsFeed - 12 Dec 2007
Scient'x USA Strengthens Leadership Team With Appointment of Bryce IntVeld as Vice President of Sales
Scient'x USA Strengthens Leadership Team With Appointment of Bryce IntVeld as Vice President of Sales
HSMN NewsFeed - 11 Dec 2007
Amedica Receives FDA Special 510(k) Clearance for its Valeo(TM) Ceramic Spinal Implant
Amedica Receives FDA Special 510(k) Clearance for its Valeo(TM) Ceramic Spinal Implant
HSMN NewsFeed - 11 Dec 2007
Cyberkinetics Receives FDA Response Letter on Andara(TM) OFS(TM) System for Acute Spinal Cord Injury
Cyberkinetics Receives FDA Response Letter on Andara(TM) OFS(TM) System for Acute Spinal Cord Injury
HSMN NewsFeed - 11 Dec 2007
Synthetic Blood Announces Progress with Oxycyte Program in Traumatic Brain Injury
Synthetic Blood Announces Progress with Oxycyte Program in Traumatic Brain Injury
HSMN NewsFeed - 11 Dec 2007
New Phase III Trial Shows Positive Outcome of lacosamide in Patients with Diabetic Neuropathic Pain
New Phase III Trial Shows Positive Outcome of lacosamide in Patients with Diabetic Neuropathic Pain
HSMN NewsFeed - 7 Dec 2007
NeuroVasx, Inc. Announces $8.5 Million Private Placement and Completion of cPAX Aneurysm Treatment Study
NeuroVasx, Inc. Announces $8.5 Million Private Placement and Completion of cPAX Aneurysm Treatment Study
HSMN NewsFeed - 6 Dec 2007
Micrus Endovascular Receives Approval to Market Stretch-Resistant Microcoils in Japan
Micrus Endovascular Receives Approval to Market Stretch-Resistant Microcoils in Japan
HSMN NewsFeed - 29 Nov 2007
UCB Announces FDA Filing for lacosamide in the Treatment of Diabetic Neuropathic Pain
UCB Announces FDA Filing for lacosamide in the Treatment of Diabetic Neuropathic Pain
HSMN NewsFeed - 29 Nov 2007
UCB Announces FDA Filing for lacosamide in the Treatment of Partial Onset Seizures in Adults with Epilepsy
UCB Announces FDA Filing for lacosamide in the Treatment of Partial Onset Seizures in Adults with Epilepsy
HSMN NewsFeed - 28 Nov 2007
Dr. Warren Wasiewski Appointed Chief Medical Officer of Neurobiological Technologies, Inc.
Dr. Warren Wasiewski Appointed Chief Medical Officer of Neurobiological Technologies, Inc.
HSMN NewsFeed - 27 Nov 2007
Neuromed Appoints Jeffrey Arcara and Gene Wright to Senior Management Team
Neuromed Appoints Jeffrey Arcara and Gene Wright to Senior Management Team
HSMN NewsFeed - 27 Nov 2007
Valeant Pharmaceuticals Completes Enrollment of Second Pivotal Phase 3 Trial for Epilepsy Drug Retigabine
Valeant Pharmaceuticals Completes Enrollment of Second Pivotal Phase 3 Trial for Epilepsy Drug Retigabine
HSMN NewsFeed - 27 Nov 2007
Fifty Hospitals Around the World Are Now Using NeuroLogica's CereTomĀ® Portable CT Scanner
Fifty Hospitals Around the World Are Now Using NeuroLogica's CereTomĀ® Portable CT Scanner
HSMN NewsFeed - 26 Nov 2007
Synergetics USA, Inc. Adds New Electrosurgical Generator to Its Neurosurgical Product Line
Synergetics USA, Inc. Adds New Electrosurgical Generator to Its Neurosurgical Product Line
HSMN NewsFeed - 20 Nov 2007
Neuralstem Obtains UCSD Stem Cell Delivery System for Use in Spinal Cord Trials
Neuralstem Obtains UCSD Stem Cell Delivery System for Use in Spinal Cord Trials
HSMN NewsFeed - 19 Nov 2007
Amarin Announces Completion of Comprehensive Data Analysis From Phase III Huntington's Disease Program
Amarin Announces Completion of Comprehensive Data Analysis From Phase III Huntington's Disease Program
HSMN NewsFeed - 15 Nov 2007
Ortoviva: Strong Growth Potential for Ortoviva's Spinal-Surgery Technology
Ortoviva: Strong Growth Potential for Ortoviva's Spinal-Surgery Technology
HSMN NewsFeed - 12 Nov 2007
BrainStorm Cell Therapeutics Secures Significant Equity Financing and Raises Research Budget
BrainStorm Cell Therapeutics Secures Significant Equity Financing and Raises Research Budget
